Clinical trial
A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer
NCT00040742 is registered in ClinicalTrials.gov with Gary Morrow as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer
- Lead sponsor
- Gary Morrow
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- December 31, 2011
- Enrollment
- 745 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.